Evidence map›Paper›PMID 28420716›Full record

ArticleEndocrine connections2017

A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control.

K E Lines, R P Vas Nunes, M Frost, C J Yates, M Stevenson, R V Thakker

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine connections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. MENIN loss as a tissue-specific driver of tumorigenesis.Molecular and cellular endocrinology · 2018
    Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K E Lines
R P Vas Nunes
M FrostAcademic Endocrine UnitOCDEM, University of Oxford, Churchill Hospital, Oxford, UK.
C J YatesAcademic Endocrine UnitOCDEM, University of Oxford, Churchill Hospital, Oxford, UK.
M StevensonAcademic Endocrine UnitOCDEM, University of Oxford, Churchill Hospital, Oxford, UK.
R V ThakkerAcademic Endocrine UnitOCDEM, University of Oxford, Churchill Hospital, Oxford, UK rajesh.thakker@ndm.ox.ac.uk.
Churchill Hospital · GBUniversity of Oxford · GB

Funding

Medical Research Council G1000467Medical Research Council G9825289
6 · The paper itself

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by occurrence of parathyroid tumours and neuroendocrine tumours (NETs) of the pancreatic islets and anterior pituitary. The

Indexed as

mouse modelmultiple endocrine neoplasiapancreatic islettamoxifen inducible

Identifiers

PMID28420716
PMCPMC5632719
OpenAlexW2607447177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.